We exploited high-throughput data analysis methods and databases to elucidate novel ESCC prognostic biomarkers and constructed an immune-related prognostic signature based on CCR5 and TSPAN2. The gene discussed is TSPAN2; the disease is esophageal squamous cell carcinoma.